There is no clear information on the frequency of adverse reactions occurring as a result ofdiethylcarbamazine citrate administration. Mild to moderate adverse reactions are common,but theincidence of serious adverse reactions is considered to be very low.In the absence of circulating microfilaraemia, the administration of diethylcarbamazine citrate, whengiven at the recommended dosage, may cause nausea, vomiting, abdominal pain, diarrhoea, loss ofappetite, muscle pain, dizziness, drowsiness, fatigue and headache. These begin within one to twohours and may persist for several hours.Â 
